(Q46191825)

English

Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Leishmania infantum

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Patrick Bastien

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Laurence Lachaud

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nathalie Bourgeois

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marie Plourde

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Philippe Leprohon

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

e16-22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19093811%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Advances in leishmaniasis

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Clinical survey of Leishmania/HIV co-infection in Catania, Italy: the impact of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Leishmania/HIV co-infections: epidemiology in Europe.

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Liposomal amphotericin B for the treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Visceral leishmaniasis and HIV-1 co-infection in southern France

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

The relationship between leishmaniasis and AIDS: the second 10 years

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Gene amplification in amphotericin B-resistant Leishmania tarentolae

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Genetic heterogeneity and phylogenetic status of Leishmania (Leishmania) infantum zymodeme MON-1: epidemiological implications

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Leishmania: risk to the blood supply

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Chromosome size and number polymorphisms in Leishmania infantum suggest amplification/deletion and possible genetic exchange

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Helicobacter pylori evolution and phenotypic diversification in a changing host

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Antifungal resistance in pathogenic fungi

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Antifungal drug resistance: limited data, dramatic impact?

1 reference

https://api.crossref.org/works/10.1086%2F595710

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46191825&oldid=1560141551"